RD14-01
/ Nanjing Bioheng Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 01, 2023
A Study of RD14-01 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=12 | Recruiting | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Metastases • New P1/2 trial • Oncology • Solid Tumor • ROR1
December 06, 2022
A Study of RD14-01 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Shen Lin
New P1 trial • Oncology • Solid Tumor • ROR1
July 05, 2022
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: He Huang
New P1 trial • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 3
Of
3
Go to page
1